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Abstract 
Purpose: 19F-Nuclear magnetic resonance spectroscopy (19F-NMR) was used to study host-guest 
complexation of three fluorine containing antidepressant drugs, viz, fluoxetine hydrochloride, citalopram 
hydrobromide and fluvoxamine maleate, with various cyclodextrins (CD), including α-, β-cyclodextrin, 
methylated α-cyclodextrin (M-α-CD), diamino derivative of methylated α-cyclodextrin, (DAM-α-CD) and 
tetramino derivative of methylated α-cyclodextrin (TAM-α-CD). 
Methods: Using the mole ratio method, a 1:1 stoichiometry was determined for the resulting inclusion 
complexes. 19F chemical shifts were used to determine the formation constant of the complexes. 
Experiments were performed with solutions containing 0.001 M drug and various concentrations of CDs. 
NMR data were plotted as 19F chemical shift versus CD/drug mole ratio, and fitted using the nonlinear 
least-squares curve fitting program, KINFIT, to obtain the formation constant of CD-drug complex. 
Molecular modeling (MM) calculations were used to predict the geometry of the complex of fluvoxamine 
and β-CD. Molecular modeling studies were performed in vacuum phase, employing empirical force 
fields and semi-empirical quantum theory using AM1 Hamiltonian. 
Results: Complex formation caused separation of the fluorine peaks that can be assigned to the two 
enantiomers of fluoxetine hydrochloride. Molecular modeling data suggest that fluvoxamine/β-CD 
inclusion complexes have a 1:1 stoichiometry and that the CF3-substituted ring of fluvoxamine is 
embedded in the cavity of β-CD, indicating a good agreement between molecular modeling calculation 
and experimental data (NMR data). 
Conclusion: One-dimensional 19F-NMR is a fast and convenient method for the determination of 
complex stoichiometry and complexation constants of natural and modified CDs and fluorinated drugs. 
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As a strategy to reduce the drawbacks of many 
pharmaceutical formulations, polymers, 
liposomes and cyclodextrins (CDs) have been 
used as controlled or sustained release systems. 
These modified release systems can provide a 
reduction of drug concentration or decrease in 
the dose administration per day. The CDs has 
attracted the attention not only in the 
pharmaceutical formulations but also in food and 
biological areas, because of their ability to form 
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inclusion compounds (ICs) with guest molecules 
in solutions or solid-state [1-3]. Indeed, CDs have 
been used extensively in pharmaceutical 
formulations as solubilizers to enhance oral 
bioavailability [4]. 
 
Cyclodextrins (CDs) are cyclic oligosaccharides 
consisting of six (α-CD), seven (β-CD), or eight 
(γ-CD) glucopyranose units in their structure [5]. 
Due to formation of α-1,4-glycosidic linkage, CDs 
are doughnut shaped molecules, possessing 
hollow cavities which can accommodate a variety 
of guests in aqueous solution and in the 
crystalline state by non-covalent interactions 
[6,7]. The presence of hydroxyl groups on the 
exterior surface of CDs make them fairly polar 
while the interior of the cavity is relatively non-
polar. The slightly hydrophobic character of the 
inner cavity provides a driving force for host-
guest complexation with similarly apolar guest 
molecules [7]. 
 
The prediction of the behavior of guests such as 
drugs in CD solution is dependent on the 
complexation constant (also called the stability or 
formation constant) for the CD-guest complex, 
and the stoichiometry of complexation. 
Measurements of complexation induced 
chemical-shift displacements (up- or downfield) 
in nuclear magnetic resonance spectroscopy as 
a function of concentrations (NMR titrations) can 
be used to determine the complexation constant 
and changes in chemical shifts resulting from 
inclusion of the guest molecule in the CD cavity. 
Compared to other methods of equilibrium 
determinations, these methods have the 
advantage of providing several independent 
signals for the evaluation of stability constants 
[8]. 
 
Fluorine (19F) NMR has been used to 
demonstrate the complexation of natural β-CD 
with perfluorinated ends of telomeric polymers [9-
11] and fluorinated amino acid derivatives [12]. 
Fluorine as a group is rare in natural compounds, 
but is a relatively common substitute in drugs. 
Some drugs have fluorine(s) in their structures, 
e.g., psychotropic drugs, synthetic steroidal 
hormones and new quinolone drugs. They are 
widely used clinically because the introduction of 
fluorine atom(s) into the drugs improves their 
pharmaceutical activities or induces new 
pharmaceutical activities [13]. This method is 
limited by the fact that a majority of drugs do not 
contain fluorine, but when it is applicable; 19F-
NMR should have certain advantages over the 
more commonly applied proton (1H) and carbon 
(13C) NMR methods. In comparison to 1H-NMR, 
the absolute chemical-shift variation is an order 
of magnitude larger for 19F-NMR, and peak 
broadening, which often makes CD 
complexation-induced chemical-shift 
determinations in 1H-NMR difficult, is less 
observed. While the absolute chemical-shift 
variation may be similar in 13C- and 19F-NMR, the 
latter method is more sensitive since the natural 
abundance of the measured isotope is 100 %, 
compared to 1.1 % for 13C, allowing less time-
consuming collection of data. Overlapping of CD 
and guest signals, which is frequently 
encountered in 1H- and 13C-NMR, is also 
eliminated. This study was aimed at investigating 
whether 19F-NMR is a suitable method for 
determination of complex stoichiometry and 
complexation constants of the natural and 
modified CDs and fluorinated drugs. The 
structures of fluorine-containing antidepressant 
drugs and modified cyclodextrins used in this 




Materials and reagents 
 
Analytical grade, high-purity substances were 
used throughout this study. Racemic fluoxetine 
(as the hydrochloride salt) was obtained from 
Recordati, Spain. Citalopram hydrobromide was 
purchased from Ranboxy, India. Fluvoxamine 
maleate was obtained from Solvay-Duphar, 
Netherlands. These drug standards were used 
without any further purification. Deuterium oxide 
(> 99.9 %) was supplied by Merck (Darmstadt, 
Germany). α- and β-Cyclodextrins were 
purchased from Fluka (Buchs, Switzerland). 
Methylated α-cyclodextrin (M-α-CD), tetramino 








(DAM-α-CD) [14] were a gift of prof. Matt 
(Laboratoire de Chimie Inorganique et Catalyse, 




All 19F-NMR spectra were recorded on a 
BRUKER DRX 500 AVANCE (11.7 T) 
spectrometer operating at 470.59 MHz 19F 
observation frequency, equipped with a 
dedicated 5-mm QNP probehead and running 
XWIN-NMR 2.6 software using 500 µl of 
samples.  
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Figure 1: Chemical structures of the fluorine-containing antidepressant drugs and the modified cyclodextrins 
used in this study 
 
In all experiments, a known amount of D2O (100 
µl) was added as an internal field frequency lock. 
Spectra were recorded at 298 ± 1 K and the 19F-
NMR chemical shifts were reported relative to 
trichlorofluoromethane (CFCl3) at δF = 0.0 ppm. 
The spectra were generally obtained in 16 to 64 




NMR data was plotted as the variation of the 19F 
chemical shift against CD/drug mole ratio and 
fitted to the following equation using the 
nonlinear least-squares curve fitting program 
KINFIT [15] to obtain the formation constant of 






where δobs is the observed chemical shift of the 
drug, Kf is the formation constant for the 1:1 
complex, CCD and CD are the analytical 
concentrations of the cyclodextrin and drug, 
respectively, and δD and δdrug-CD are the 





19F NMR spectra of fluoxetine hydrochloride were 
obtained in aqueous solution in the absence and 
presence of increasing amount of different 
cyclodextrins. Experiments were performed with 
solutions containing 0.001 M fluoxetine and 
having different concentrations of CDs (α-CD, M-
α-CD, DAM-α-CD, TAM-α-CD and β-CD). All the 
spectra contained one set of resonances 
suggesting a fast equilibrium between the free 
and complexed forms of the drug, on the NMR 
time scale. 
 
Typically, the changes observed in the 
successive 19F NMR spectra of fluoxetine upon 
addition of M-α-CD and DAM-α-CD is shown in 
Figure 2. The 19F chemical shifts of each of the 
two fluoxetine hydrochloride enantiomers as a 
function of CD/fluoxetine mole ratios in the 
presence of M-α-CD, DAM-α-CD, TAM-α-CD and 
β-CD are illustrated in Figure 3. 
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Figure 2: 19F-NMR spectra of 0.001 M fluoxetine hydrochloride at various CD/fluoxetine mole ratios in the 
presence of M-α-CD (A) and DAM-α-CD (B) 
 
Kf values were obtained from nonlinear fitting the 
δobs versus CCD data (at constant CD of 0.001 M) 
to Eq 1. A sample computer fit of the 19F 
chemical shift against M-α-CD/fluoxetine mole 
ratio data for the (R)-fluoxetine and (S)-
fluoxetine is shown in Figure 4 and the 
calculated log Kf values for each of the fluoxetine 
enantiomers are given in Table 1.  As it can be 
observed in Figure 4, a good agreement 
between the experimental and calculated 
chemical shifts supports the formation of a 
complex with 1:1 stoichiometry between drug 
and CD. 
 
In the present work, it also investigated the 
complexation of citalopram hydrobromide and 
fluvoxamine maleate with α-CD, M-α-CD, DAM-
α-CD and β-CD. Experiments were performed 
with solutions containing 0.001 M drug and 
having different concentrations of CDs. The Kf 
values were evaluated by fitting the chemical 
shift-mole ratio data to Eq 1 using the KINFIT 
program for a 1:1 complex model. The resulting 
log Kf values are included in Table 1. 
 
The results from the 19F-NMR study show that 
the fluvoxamine phenyl group with the –CF3 
substitution remains outside the α-CD cavity, as 
it does not undergo any significant spectral 
changes. 
 
In order to gain further insights into the inclusion 
process, molecular modeling (MM) calculations 
was used to predict the geometry of the complex 
of fluvoxamine and β-CD. Molecular modeling 
studies were performed in vacuum phase 
employing the empirical force fields and 
semiempirical quantum theory using the AM1 
Hamiltonian. The initial geometry of fluvoxamine 
was obtained using a full geometry optimization 
at the level of B3LYP/6-31 + + G** and the initial 
geometry of β-CD was obtained using a full 
geometry optimization at the level of AM1 based 
on the available crystallography data [16]. The 
initial docked structure of the inclusion complex 
of fluvoxamine and β-CD was obtained using the 
simulated annealing method, with a rigid 
geometry and fixed partial charges for the 
individual molecules. The calculations were 
performed by HyperChem [17] and Gaussian 98 
packages of program [18]. The minimum energy 





In the 19F-NMR spectra, fluoxetine has one 
strong singlet at -61.3 ppm. Fluoxetine is a 
racemic mixture and addition of different CDs 
(except α-CD) resulted in separation of the 
enantiomers in the 19F-NMR spectra, with 
different chemical shifts for either enantiomer. In 
fact, because of the formation of diastereomeric 
complexes between the CDs and the fluoxetine 
enantiomers, a doublet set of more or less 
shifted signals can be seen for the 
diastereomers. Thus, the presence of two 
enantiomers can be demonstrated simply by the 
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Figure 3: Fluorine-19 chemical shifts of each of the two fluoxetine hydrochloride enantiomers as a function of 




Figure 4: Computer fit of 19F chemical shift vs. M-α-CD/fluoxetine mole ratio for the (R)-fluoxetine (A) and (S)-
fluoxetine (B): (×) experimental point; (○) calculated point; (=) experimental and calculated points are the same 
within the resolution of the plot 
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Table 1: Formation constants of 1:1 complexes of fluoxetine, citalopram and fluvoxamine with the natural and 
modified cyclodextrins 
 
Cyclodextrin log Kf a 
 (R)-Fluoxetine (S)-Fluoxetine Citalopram Fluvoxamine 
α-CDb 1.50 ± 0.08 1.50 ± 0.08 2.54 ± 0.07 --- 
M-α-CD 2.90 ± 0.02 2.85 ± 0.03 3.31 ± 0.03 2.82 ± 0.02 
DAM-α-CD 2.49 ± 0.07 2.37 ± 0.02 2.96 ± 0.03 2.02 ± 0.06 
TAM-α-CD 2.43 ± 0.04 2.30 ± 0.06 --- --- 
β-CD 3.32 ± 0.07 3.37 ± 0.06 2.97 ± 0.04 3.29 ± 0.07 





Figure 5: Relative host-guest geometry corresponding to the minimum of the energy of the formation of 
fluvoxamine/β-CD complex. Top view (A) and side view (B) 
 
addition of CD, and equal size of the peaks 
confirmed that the enantiomers were present in 
equimolar quantities. 
 
The data given in Table 1 clearly indicate the 
formation constants are almost the same for both 
enantiomers of fluoxetine with CDs, showing that 
the extent of inclusion of the guest into the CD 
cavity is the similar for two enantiomers. 19F-
NMR spectroscopy of mixtures of fluoxetine 
hydrochloride and different CDs revealed the 
existence of inclusion complexes formed by the 
penetration of CF3-substituted ring into the CD 
cavity, in analogy to previously reported findings 
for complex of fluoxetine with β-CD [3,7]. 
 
A primary criterion for the inclusion of a guest 
molecule within the host’s cavity is obviously its 
size and then other factors such as strict fit, van 
der Waals’ interactions, hydrogen bonding and 
so on [19,20]. As can be seen in the Table 1, the 
Kf values obtained for the complexes of 
fluoxetine and fluvoxamine with β-CD is 
somewhat higher than the other cyclodextrins. It 
is most possibly due to the consonance between 
the size of β-CD cavity and the size of included 
group inside cavity. 
 
It is interesting to note that, methylated 
derivatives of α-CD possess stronger ability for 
the complexation than the parent α-CD. This 
probably reflects the ability of flexible 
permethylated CDs to better adapt their shape to 
that of the included guest molecules. Chemical 
modification [21], notably permethylation, often 
renders the macrocyclic structure much more 
flexible as a result of interglucose O(2)n...O(3)n-
1 hydrogen bond breaking which can lead to 
significant shape modification of the torus 
[22,23]. It is pointed out that per-2,3,6-methylated 
CDs are more water soluble at room temperature 
than their natural analogues and retain inclusion 
properties to a certain extent [24]. Furthermore, a 
comparison between the binding constant values 
of resulting 1:1 complexes of fluoxetine molecule 
with modified α-CDs show that the structure of 
B,C,E,F-tetrafunctionalized methylated α-CD has 
become more rigid than A,D-difunctionalized 
methylated α-CD. 
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The Kf values obtained for the complex of 
citalopram with different CDs (Table 1) reveal the 
permethylation of cyclodextrins enhance their 
complex forming ability. As mentioned above, it 
can be explained by changes in the shape of the 
cyclodextrin cavity to accommodate the guest 
molecule. 
 
The molecular modeling data suggest that 
fluvoxamine/β-CD inclusion complexes have a 
1:1 stoichiometry and that the CF3-substituted 
ring of fluvoxamine is embedded in the cavity of 
β-CD (Figure 5). Therefore, the results reported 
show a good agreement between MM calculation 




19F-NMR titrations and mole ratio methods are 
easy to perform and fast. These methods can be 
used to determine complexation stoichiometry 
and formation constants between fluorine-
containing drugs and CD derivatives, provided 
that the fluorine is embedded into the CD cavity 
when the complex is formed. For convenient use 
of this method, the drug must have a relatively 
high intrinsic solubility so that the acquisition time 
for each sample is within few minutes. This 
method could be used to measure enantiomeric 
composition of chiral compounds, since only very 
small additions of CD cause separation of peaks 
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